China Clinical Trial Biorepository & Archiving Solutions Market Size & Outlook
China clinical trial biorepository & archiving solutions market, 2018-2030 (US$M)
Related Markets
China clinical trial biorepository & archiving solutions market highlights
- The China clinical trial biorepository & archiving solutions market generated a revenue of USD 112.4 million in 2023 and is expected to reach USD 296.3 million by 2030.
- The China market is expected to grow at a CAGR of 14.9% from 2024 to 2030.
- In terms of segment, biorepository services was the largest revenue generating service in 2023.
- Biorepository Services is the most lucrative service segment registering the fastest growth during the forecast period.
Clinical trial biorepository & archiving solutions market data book summary
| Market revenue in 2023 | USD 112.4 million |
| Market revenue in 2030 | USD 296.3 million |
| Growth rate | 14.9% (CAGR from 2023 to 2030) |
| Largest segment | Biorepository services |
| Fastest growing segment | Biorepository Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biorepository Services, Archiving Solution Services |
| Key market players worldwide | Azenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc |
Other key industry trends
- In terms of revenue, China accounted for 2.8% of the global clinical trial biorepository & archiving solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China clinical trial biorepository & archiving solutions market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 296.3 million by 2030.
Biorepository services was the largest segment with a revenue share of 66.37% in 2023. Horizon Databook has segmented the China clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.
China is one of the lucrative markets for clinical trial biorepository & archiving solutions players owing to its diverse pool of patients and growing pharmaceutical market. Logistics and supply chain is a major challenge in the country, which is discouraging major biopharmaceutical companies from conducting trials in China. The country accounts for 34.83% of global clinical trials conducted as of 2020 and has exhibited lucrative growth in the past 3 years.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Biorepository & Archiving Solutions Market Scope
Clinical Trial Biorepository & Archiving Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China clinical trial biorepository & archiving solutions market size, by service, 2018-2030 (US$M)
China Clinical Trial Biorepository & Archiving Solutions Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
